Human papillomavirus knowledge and vaccine acceptability among male medical students in Saudi Arabia

Figures & data

Table 1. Sociodemographic characteristics of the participants

Sample characteristics*	N (%) N = 517
Age, mean ± SD	21 ± 1.4
Nationality^†
Saudi	492 (96.3)
Non-Saudi	19 (3.7)
Marital status
Single	515 (99.6)
Married	2 (0.4)
Have children
No	515 (99.6)
Yes	2 (0.4)
Medical school year
Preclinical (third year)	245 (47.4)
Clinical (fourth year)	272 (52.6)
Cumulative GPA^†
Low	33 (6.4)
High	474 (93.5)
Smoking^†
Never smoker	376 (73.2)
Ever smoker	138 (26.8)
Previously received hepatitis B vaccine^†
No	224 (43.8)
Yes	287 (56.2)
History of any sexually transmitted disease^†
No	508 (99.4)
Yes	3 (0.6)

*Data are given as number (%) except where otherwise indicated.

^†The number of participants who responded to the question does not equal total participants due to missing values.

GPA, grade point average.

Figure 1. Source of human papillomavirus knowledge

Table 2. Logistic regression analysis of the predictors of HPV knowledge

Variable	Poor HPV knowledge	Good HPV knowledge	Univariate OR and 95% CI*	Multivariate OR and 95% CI*
Medical school year Clinical Preclinical	228 196	23 37	1 1.87 (1.07–3.25)	1 1.92 (1.09–3.38)
Cumulative GPA Low High	29 386	4 56	1 1.05 (0.35–3.10)	1 1.36 (0.39–4.73)
Smoking Never smoker Ever smoker	304 117	47 13	1 0.71 (0.37–1.37)	1 0.73 (0.37–1.41)
Hepatitis B vaccine Yes No	239 180	38 21	1 0.73 (0.41–1.29)	1 0.73 (0.41–1.31)

*Subjects with missing variable responses were excluded from the regression analysis.

HPV, human papillomavirus; GPA, grade point average; OR, odds ratio; CI, confidence interval

Table 3. Human papillomavirus (HPV) vaccine acceptability among the participants

Questions about HPV vaccine	N (%) N = 517
Would you be interested in getting the HPV vaccine? * No Yes I don’t know	125 (24.4) 251 (48.9) 137 (26.7)
Have you ever received an HPV vaccine?* No Yes I don’t know	222 (44.9) 43 (8.7) 229 (46.4)
Do you think vaccine awareness programs would help you to decide whether to take the vaccine or not? * No Yes	103 (20.6) 396 (79.4)
Do you plan to discuss the HPV vaccine with your female patients? * No Yes	230 (44.8) 283 (55.2)
Do you plan to discuss the HPV vaccine with your male patients? * No Yes	220 (43.1) 290 (56.9)

*The number of participants who responded to the question does not equal total participants due to missing values.

Table 4. Predictors of willingness to receive the HPV vaccine

	Willingness to receive HPV vaccine
Predictor	Yes	No	Univariate OR and 95% CI*	Multivariate OR and 95% CI*
HPV knowledge Good Poor	34 206	20 96	1 1.26 (0.69–2.30)	1 1.10 (0.57–2.11)
HPV vaccine knowledge Good Poor	2 240	3 119	1 3.02 (0.49–18.35)	1 2.8 (0.41–19.9)
Medical school year Clinical Preclinical	133 118	57 68	1 0.74 (0.48–1.14)	1 0.84 (0.41–1.36)
Nationality Non-Saudi Saudi	8 240	10 115	1 2.60 (1.00–6.78)	1 2.10 (0.76–5.82)
Cumulative GPA Low High	16 229	5 117	1 0.61 (0.21–1.71)	1 0.51 (0.17–1.51)
Smoking Never smoker Ever smoker	181 69	91 33	1 1.05 (0.64–1.70)	1 0.99 (0.59–1.67)
Hepatitis B vaccine Yes No	146 101	60 65	1 0.63 (0.41–0.98)	1 0.62 (0.39–1.00)

*Subjects with missing variable responses were excluded from the regression analysis.

HPV, human papillomavirus; GPA, grade point average; OR, odds ratio; CI, confidence interval.

Figure 2. Reasons for refusing to take the human papillomavirus (HPV) vaccine. Participants were asked about their reasons only if they were not interested in receiving the vaccine (n = 125). STD = sexually transmitted disease